Literature DB >> 7978702

Diagnosis and treatment of primary hyperaldosteronism.

J D Blumenfeld1, J E Sealey, Y Schlussel, E D Vaughan, T A Sos, S A Atlas, F B Müller, R Acevedo, S Ulick, J H Laragh.   

Abstract

OBJECTIVE: To characterize the clinical and laboratory features of primary aldosteronism and to evaluate which diagnostic tests can discriminate surgically curable forms of this syndrome.
DESIGN: Retrospective analysis of the following data from 82 patients with primary aldosteronism: blood pressure, serum electrolytes, urinary aldosterone and electrolytes, computed tomographic scans, plasma renin and aldosterone before and during upright posture, atrial natriuretic peptide, and adrenal vein aldosterone and cortisol. Clinical outcomes assessed after treatment included blood pressure, serum electrolytes, and plasma renin activity.
RESULTS: Drug therapy was discontinued before diagnostic tests were done in 56 of 82 patients (34 with adenomas and 22 with hyperplasia). Compared with patients with hyperplasia, those with adenomas had higher systolic (184 mm Hg and 161 mm Hg, respectively; P < 0.001) and diastolic blood pressures (112 mm Hg and 105 mm Hg; P = 0.03), lower serum potassium levels (3.0 mmol/L and 3.5 mmol/L; P < 0.001), and higher serum CO2 (P = 0.001), atrial natriuretic peptide (P = 0.008), and urinary 18-methyl oxygenated cortisol metabolite levels (P = 0.02). In patients with adenomas, aldosterone secretion lateralized to one adrenal gland and did not increase during the postural stimulation test; preoperative urinary aldosterone levels were correlated with diastolic pressures (r = 0.58; P = 0.001). Hypertension was "cured" postoperatively in approximately 35% of patients with adenomas and those with hyperplasia (P > 0.2) but was "improved" more frequently in those with adenomas (P = 0.002). Cured patients from both groups were younger than those not cured (mean ages, 43 years and 54 years, respectively; P = 0.002) and had lower preoperative mean plasma renin activity (0.17 ng/mL per hour and 0.50 ng/mL per hour; P < 0.001). All patients with adenomas in whom aldosterone secretion lateralized were either cured or improved.
CONCLUSION: Of the 51 patients with primary aldosteronism who had adrenalectomy (43 patients with adenomas and 8 with hyperplasia), those most likely to be cured were younger and had lower plasma renin activity. In patients with adenomas who were cured or improved, aldosterone secretion was more likely to lateralize. Tests that distinguished adenomas from adrenal hyperplasia included the postural stimulation test, urinary excretion rates of 18-oxocortisol and 18-hydroxycortisol, and adrenal vein sampling.

Entities:  

Mesh:

Year:  1994        PMID: 7978702     DOI: 10.7326/0003-4819-121-11-199412010-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  35 in total

1.  Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report.

Authors:  L Zinnamosca; L Petramala; D Cotesta; C Marinelli; S Sciomer; G Cavallaro; A Ciardi; R Massa; G De Toma; S Filetti; C Letizia
Journal:  Endocrine       Date:  2010-12       Impact factor: 3.633

2.  The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas.

Authors:  Edson F Nogueira; Daniel Gerry; Franco Mantero; Barbara Mariniello; William E Rainey
Journal:  Clin Endocrinol (Oxf)       Date:  2009-10-28       Impact factor: 3.478

3.  Outcome of surgery for primary hyperaldosteronism.

Authors:  Jens Waldmann; Lisa Maurer; Julia Holler; Peter H Kann; Annette Ramaswamy; Detlef K Bartsch; Peter Langer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 4.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

5.  Value of adrenal venous sampling for lesion localization in primary aldosteronism.

Authors:  Eun Mee Oh; Kyu Eun Lee; Kwan Yoon; Seong Yeon Kim; Hyo-Cheol Kim; Yeo-Kyu Youn
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 6.  The effect of aldosterone on glucose metabolism.

Authors:  Dalila B Corry; Michael L Tuck
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

7.  Predictors of malignancy in primary aldosteronism.

Authors:  Ayman Agha; Matthias Hornung; Igors Iesalnieks; Andreas Schreyer; Ernst Michael Jung; Assad Haneya; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2013-09-19       Impact factor: 3.445

8.  Intrarenal hemodynamics in primary aldosteronism before and after treatment.

Authors:  Leonardo A Sechi; Alessandro Di Fabio; Massimo Bazzocchi; Alessandro Uzzau; Cristiana Catena
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

Review 9.  Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.

Authors:  Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Orphanet J Rare Dis       Date:  2010-05-19       Impact factor: 4.123

10.  Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma.

Authors:  Ra Mi Kim; Jandee Lee; Euy-Young Soh
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.